Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
US Department of Justice
Daiichi Sankyo

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206289

« Back to Dashboard

NDA 206289 describes ATROPINE SULFATE, which is a drug marketed by Us Army, Akorn, Fresenius Kabi Usa, and Hospira, and is included in four NDAs. It is available from four suppliers. Additional details are available on the ATROPINE SULFATE profile page.

The generic ingredient in ATROPINE SULFATE is atropine sulfate. There are twenty-three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the atropine sulfate profile page.
Summary for 206289
Ingredient:atropine sulfate
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 206289
Suppliers and Packaging for NDA: 206289
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ATROPINE SULFATE atropine sulfate SOLUTION/DROPS;OPHTHALMIC 206289 NDA MWI 13985-606 N 13985-606-05
ATROPINE SULFATE atropine sulfate SOLUTION/DROPS;OPHTHALMIC 206289 NDA Akorn, Inc. 17478-215 N 17478-215-02

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength1%
Approval Date:Jul 18, 2014TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Federal Trade Commission
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.